Plant Compound Fights Leukemia – Surrey University Research
“`html
Forskolin, a compound from the Woolly Plectranthus Plant, shows Promise in Fighting Acute Myeloid Leukemia
Table of Contents
Published: August 27, 2024, 5:25 AM PDT
Updated: august 27, 2024, 5:25 AM PDT
Overview
Researchers have identified a naturally occurring compound, forskolin, extracted from the woolly Plectranthus plant (Plectranthus barbatus), that demonstrates a “dual mechanism of action” in combating acute myeloid leukemia (AML), a particularly aggressive form of blood cancer. The study, published on August 20, 2024, in the British Journal of Pharmacology, suggests forskolin not only directly impacts cancer cells but also enhances the effectiveness of conventional chemotherapy.

The Dual Mechanism of Action
Forskolin exhibits a two-pronged approach to fighting AML. First, it directly impacts leukemia cells. Second, it tackles a key challenge in AML treatment: drug resistance. The compound works by blocking a protein that allows cancer cells to resist chemotherapy drugs, effectively making the treatment more potent. This allows more of the chemotherapy drug to enter the leukemia cells, increasing its effectiveness.
Dr. Maria Teresa Esposito, a biochemistry lecturer at the University of Surrey and involved in the study, stated that the finding “could lead to a more effective treatment strategy” for patients with AML. She further suggested that utilizing forskolin could potentially allow for lower doses of chemotherapy to be used, thereby reducing the debilitating side effects often associated with AML treatments.
Research Collaboration and Funding
The research was a collaborative effort involving the University of Surrey, the University of Roehampton, Queen Mary University of London, and university College London. The study was funded by Leukaemia UK, a leading charity dedicated to improving the lives of people with blood cancer.
Implications for AML Treatment
Dr. Simon Ridley,Director of Research at Leukaemia UK,emphasized the significance of the findings. “AML is one of the most aggressive and deadly cancer types,and this study opens the door to kinder,more effective treatments,” he said. Leukaemia UK is committed to funding innovative research and views this work as essential to achieving their goal of doubling the five-year survival rate for AML within the next decade.
The potential to reduce chemotherapy dosage is particularly noteworthy. Common side effects of AML chemotherapy include nausea, vomiting, hair loss, and increased susceptibility to infection. Lowering the dose while maintaining efficacy could considerably improve patients’ quality of life during treatment.
Forskolin: Origin and Traditional Uses
the woolly Plectranthus plant is native to Africa and Asia and has a history of traditional medicinal use. Forskolin, a labdane diterpene, has been traditionally used in Ayurvedic medicine
